Literature DB >> 29105799

Microdialysis as a tool to determine the local tissue concentration of dicloxacillin in man.

Kristian Kraft Hansen1, Flemming Nielsen2, Tore Bjerregaard Stage2, Uffe Jørgensen1, Ole Skov1, Lasse E Rasmussen3.   

Abstract

AIMS: The most common pathogen to cause postoperative infections in Denmark is Staphylococcus aureus. Despite using prophylactic antibiotics, infections are still seen. Whether the tissue concentration is above the minimal inhibitory concentration (MIC) for the pathogen is unknown. Thus, the concentration of dicloxacillin in muscle and adipose tissue was measured after intravenous administration, in healthy men.
METHODS: MIC for dicloxacillin against S. aureus was determined using the broth macrodilution method. A microdialysis (MD) catheter was placed in the subcutaneous tissue of the abdomen and in the lateral vastus muscle of the thigh of six healthy male volunteers. They were given 2 g dicloxacillin intravenously. Samples from blood and MD fluid were collected. The unbound dicloxacillin was isolated from plasma. Samples were analysed with high performance liquid chromatography (HPLC).
RESULTS: The maximum concentration was reached in muscle tissue after 0.5 h and in adipose tissue after 0.8 h. AUC0-6h for the dicloxacillin concentration in adipose tissue was significantly lower when compared to the unbound dicloxacillin concentration in plasma. The dicloxacillin concentration was above the MIC for sensitive S. aureus for a minimum of 2.3 h and a median of 4.1 h in muscle tissue and a minimum of 1.8 h and a median of 3.2 h in adipose tissue.
CONCLUSIONS: The unbound dicloxacillin concentration in adipose and muscle tissue remained above the MIC for sensitive S. aureus, for a period sufficient for many orthopaedic procedures. Whether this is true in patients with compromised circulation remains to be investigated.
© 2017 The British Pharmacological Society.

Entities:  

Keywords:  dicloxacillin; microdialysis; prophylactic antibiotics; tissue pharmacokinetics

Mesh:

Substances:

Year:  2017        PMID: 29105799      PMCID: PMC5809352          DOI: 10.1111/bcp.13468

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

Review 1.  Science, medicine, and the future: Microdialysis.

Authors:  Markus Müller
Journal:  BMJ       Date:  2002-03-09

2.  Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysis.

Authors:  Catharine C Bulik; Dora E Wiskirchen; Ashley Shepard; Christina A Sutherland; Joseph L Kuti; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

3.  Microdialysis of proteins: performance of the CMA/20 probe.

Authors:  Alan J Rosenbloom; David M Sipe; Victor W Weedn
Journal:  J Neurosci Methods       Date:  2005-07-25       Impact factor: 2.390

4.  Risk Factors for Infection Following Total Knee Arthroplasty: A Series of 3836 Cases from One Institution.

Authors:  Brooks Crowe; Ashley Payne; Perry J Evangelista; Anna Stachel; Michael S Phillips; James D Slover; Ifeoma A Inneh; Richard Iorio; Joseph A Bosco
Journal:  J Arthroplasty       Date:  2015-07-02       Impact factor: 4.757

5.  Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditions.

Authors:  Alexander Kratzer; Uwe Liebchen; Michael Schleibinger; Martin G Kees; Frieder Kees
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-05-17       Impact factor: 3.205

6.  Penetration of ertapenem into muscle measured by in vivo microdialysis in mechanically ventilated patients.

Authors:  I Boyadjiev; A Boulamery; N Simon; C Martin; B Bruguerolle; M Leone
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

7.  Microdialysis as a tool to determine the local tissue concentration of dicloxacillin in man.

Authors:  Kristian Kraft Hansen; Flemming Nielsen; Tore Bjerregaard Stage; Uffe Jørgensen; Ole Skov; Lasse E Rasmussen
Journal:  Br J Clin Pharmacol       Date:  2017-12-07       Impact factor: 4.335

8.  A diagnostic tool for population models using non-compartmental analysis: The ncappc package for R.

Authors:  Chayan Acharya; Andrew C Hooker; Gülbeyaz Yıldız Türkyılmaz; Siv Jönsson; Mats O Karlsson
Journal:  Comput Methods Programs Biomed       Date:  2016-02-17       Impact factor: 5.428

9.  Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.

Authors:  April Barbour; Stephan Schmidt; W Robert Rout; Kfir Ben-David; Olaf Burkhardt; Hartmut Derendorf
Journal:  Int J Antimicrob Agents       Date:  2009-05-02       Impact factor: 5.283

10.  Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration.

Authors:  B L Røder; N Frimodt-Møller; F Espersen; S N Rasmussen
Journal:  Infection       Date:  1995 Mar-Apr       Impact factor: 3.553

View more
  2 in total

1.  Is the penetration of clindamycin into the masseter muscle really enough to treat odontogenic infections?

Authors:  Paula I Faggion; Gabriela Isoton; Eduarda Possa; Leandro Tasso
Journal:  Clin Oral Investig       Date:  2020-10-31       Impact factor: 3.573

2.  Microdialysis as a tool to determine the local tissue concentration of dicloxacillin in man.

Authors:  Kristian Kraft Hansen; Flemming Nielsen; Tore Bjerregaard Stage; Uffe Jørgensen; Ole Skov; Lasse E Rasmussen
Journal:  Br J Clin Pharmacol       Date:  2017-12-07       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.